Clinical Trials Browser

OTHER × Carcinoma × Tetanus Toxoid × Clear all

NCT01644968 2022-05-17

Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer

Phase 1 Completed

LymphoidSarcoma

Carcinoma, Lymphoma, Sarcoma